Published in Epilepsy Behav on March 17, 2008
Estradiol acutely suppresses inhibition in the hippocampus through a sex-specific endocannabinoid and mGluR-dependent mechanism. Neuron (2012) 1.36
The role of neurosteroids in the pathophysiology and treatment of catamenial epilepsy. Epilepsy Res (2009) 1.27
Sex as a Biological Variable: Who, What, When, Why, and How. Neuropsychopharmacology (2016) 1.13
Neurosteroids and epilepsy. Curr Opin Neurol (2010) 0.92
GABAergic neuroactive steroids: a new frontier in bipolar disorders? Behav Brain Funct (2012) 0.91
Neuroendocrine aspects of catamenial epilepsy. Horm Behav (2012) 0.90
Influence of 17beta-estradiol and progesterone on GABAergic gene expression in the arcuate nucleus, amygdala and hippocampus of the rhesus macaque. Brain Res (2009) 0.88
Uncovering steroidopathy in women with autism: a latent class analysis. Mol Autism (2014) 0.87
Progesterone therapy in women with intractable catamenial epilepsy. Adv Biomed Res (2013) 0.84
Estradiol regulates large dense core vesicles in the hippocampus of adult female rats. Brain Struct Funct (2013) 0.77
Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry (2005) 45.33
Sex and depression in the National Comorbidity Survey. I: Lifetime prevalence, chronicity and recurrence. J Affect Disord (1994) 6.61
Ovarian cycle-linked changes in GABA(A) receptors mediating tonic inhibition alter seizure susceptibility and anxiety. Nat Neurosci (2005) 4.17
Neurosteroids: endogenous regulators of the GABA(A) receptor. Nat Rev Neurosci (2005) 4.07
Estradiol mediates fluctuation in hippocampal synapse density during the estrous cycle in the adult rat. J Neurosci (1992) 3.56
Hormones and menopausal status as predictors of depression in women in transition to menopause. Arch Gen Psychiatry (2004) 3.13
Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome. N Engl J Med (1998) 2.81
Estradiol increases the sensitivity of hippocampal CA1 pyramidal cells to NMDA receptor-mediated synaptic input: correlation with dendritic spine density. J Neurosci (1997) 2.39
Three patterns of catamenial epilepsy. Epilepsia (1997) 2.29
Efficacy of progesterone and progestogens in management of premenstrual syndrome: systematic review. BMJ (2001) 2.23
Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine. Proc Natl Acad Sci U S A (1998) 2.12
The influence of gonadal hormones on neuronal excitability, seizures, and epilepsy in the female. Epilepsia (2006) 2.06
Cortical gamma-aminobutyric acid levels across the menstrual cycle in healthy women and those with premenstrual dysphoric disorder: a proton magnetic resonance spectroscopy study. Arch Gen Psychiatry (2002) 2.01
Lack of effect of induced menses on symptoms in women with premenstrual syndrome. N Engl J Med (1991) 1.80
Increase in prefrontal cortex serotonin 2A receptors following estrogen treatment in postmenopausal women. Am J Psychiatry (2003) 1.77
Epileptic seizures in women related to plasma estrogen and progesterone during the menstrual cycle. Acta Neurol Scand (1976) 1.68
Evaluation of a unique oral contraceptive in the treatment of premenstrual dysphoric disorder. J Womens Health Gend Based Med (2001) 1.65
Stress-induced deoxycorticosterone-derived neurosteroids modulate GABA(A) receptor function and seizure susceptibility. J Neurosci (2002) 1.49
The neurosteroid dehydroepiandrosterone sulfate is an allosteric antagonist of the GABAA receptor. Brain Res (1990) 1.48
Fluoxetine and norfluoxetine stereospecifically and selectively increase brain neurosteroid content at doses that are inactive on 5-HT reuptake. Psychopharmacology (Berl) (2006) 1.48
Relationship between symptom severity and steroid variation in women with premenstrual syndrome: study on serum pregnenolone, pregnenolone sulfate, 5 alpha-pregnane-3,20-dione and 3 alpha-hydroxy-5 alpha-pregnan-20-one. J Clin Endocrinol Metab (1996) 1.46
Neurosteroids, via sigma receptors, modulate the [3H]norepinephrine release evoked by N-methyl-D-aspartate in the rat hippocampus. Proc Natl Acad Sci U S A (1995) 1.43
Fluoxetine-elicited changes in brain neurosteroid content measured by negative ion mass fragmentography. Proc Natl Acad Sci U S A (1996) 1.42
Lactate infusion induces panic attacks in patients with premenstrual syndrome. Psychosom Med (1992) 1.41
Neurosteroids: expression of steroidogenic enzymes and regulation of steroid biosynthesis in the central nervous system. Pharmacol Rev (1999) 1.40
The effect of menopause and perimenopause on the course of epilepsy. Epilepsia (1999) 1.40
Frequency of catamenial seizure exacerbation in women with localization-related epilepsy. Ann Neurol (2004) 1.34
Estrogens and epilepsy: why are we so excited? Neuroscientist (2007) 1.34
Short-term steroid treatment increases delta GABAA receptor subunit expression in rat CA1 hippocampus: pharmacological and behavioral effects. Neuropharmacology (2005) 1.33
Psychiatric comorbidity in chronic epilepsy: identification, consequences, and treatment of major depression. Epilepsia (2000) 1.33
Best practice guidelines for the management of women with epilepsy. Epilepsia (2005) 1.33
To what extent do oral contraceptives influence mood and affect? J Affect Disord (2002) 1.32
Gas chromatographic-mass fragmentographic quantitation of 3 alpha-hydroxy-5 alpha-pregnan-20-one (allopregnanolone) and its precursors in blood and brain of adrenalectomized and castrated rats. J Neurosci (1995) 1.31
Progesterone metabolite allopregnanolone in women with premenstrual syndrome. Obstet Gynecol (1997) 1.31
Potentiation of neuronal NMDA response induced by dehydroepiandrosterone and its suppression by progesterone: effects mediated via sigma receptors. J Neurosci (1996) 1.26
Allopregnanolone levels and reactivity to mental stress in premenstrual dysphoric disorder. Biol Psychiatry (2001) 1.25
Pharmacology of endogenous neuroactive steroids. Crit Rev Neurobiol (2003) 1.20
Decreased cerebrospinal fluid allopregnanolone levels in women with posttraumatic stress disorder. Biol Psychiatry (2006) 1.19
Progesterone therapy in women with complex partial and secondary generalized seizures. Neurology (1995) 1.18
Clobazam in catamenial epilepsy. A model for evaluating anticonvulsants. Lancet (1982) 1.17
The role of estrogens in catamenial exacerbation of epilepsy. Neurology (1959) 1.16
Steroid hormones and neurosteroids in normal and pathological aging of the nervous system. Prog Neurobiol (2003) 1.15
Progesterone therapy in women with epilepsy: a 3-year follow-up. Neurology (1999) 1.14
Steroid withdrawal in the mouse results in anxiogenic effects of 3alpha,5beta-THP: a possible model of premenstrual dysphoric disorder. Psychopharmacology (Berl) (2005) 1.13
Treatment of premenstrual dysphoric disorder with a new drospirenone-containing oral contraceptive formulation. Contraception (2005) 1.12
Mood, sexuality, hormones, and the menstrual cycle. II. Hormone levels and their relationship to the premenstrual syndrome. Psychosom Med (1983) 1.12
Pathogenesis in menstrual cycle-linked CNS disorders. Ann N Y Acad Sci (2003) 1.11
Patients with premenstrual syndrome have a different sensitivity to a neuroactive steroid during the menstrual cycle compared to control subjects. Neuroendocrinology (1998) 1.11
The role of hormones and hormonal treatments in premenstrual syndrome. CNS Drugs (2003) 1.10
Circulating levels of anxiolytic steroids in the luteal phase in women with premenstrual syndrome and in control subjects. J Clin Endocrinol Metab (1994) 1.10
Abnormal luteal phase excitability of the motor cortex in women with premenstrual syndrome. Biol Psychiatry (2003) 1.09
Luteal-phase accentuation of acoustic startle response in women with premenstrual dysphoric disorder. Neuropsychopharmacology (2007) 1.08
Reproductive endocrine disorders in women with partial seizures of temporal lobe origin. Arch Neurol (1986) 1.08
Mood, depression, and reproductive hormones in the menopausal transition. Am J Med (2005) 1.05
Progesterone prevents estradiol-induced dendritic spine formation in cultured hippocampal neurons. Neuroendocrinology (2000) 1.05
Role of neurosteroids in catamenial epilepsy. Epilepsy Res (2004) 1.04
The serotonergic and noradrenergic effects of antidepressant drugs are anticonvulsant, not proconvulsant. Epilepsy Behav (2005) 1.03
Ganaxolone. Neurotherapeutics (2007) 1.02
Progesterone reduces pentylenetetrazol-induced ictal activity of wild-type mice but not those deficient in type I 5alpha-reductase. Epilepsia (2002) 1.02
Patients with premenstrual syndrome have reduced sensitivity to midazolam compared to control subjects. Neuropsychopharmacology (1997) 1.01
Allopregnanolone concentrations and premenstrual syndrome. Eur J Endocrinol (2000) 0.99
A double-blind trial of oral progesterone, alprazolam, and placebo in treatment of severe premenstrual syndrome. JAMA (1995) 0.99
Treatment of seizures with medroxyprogesterone acetate: preliminary report. Neurology (1984) 0.98
Ovarian steroid regulation of tryptophan hydroxylase mRNA expression in rhesus macaques. J Neurosci (1996) 0.97
Clomiphene therapy in epileptic women with menstrual disorders. Neurology (1988) 0.97
A placebo-controlled study of effects of oral progesterone on performance and mood. Br J Clin Pharmacol (1992) 0.97
Withdrawal properties of a neuroactive steroid: implications for GABA(A) receptor gene regulation in the brain and anxiety behavior. Steroids (2002) 0.97
Allopregnanolone levels and symptom improvement in severe premenstrual syndrome. J Clin Psychopharmacol (2002) 0.96
Catamenial epilepsy: pathophysiology, diagnosis, and management. Neurology (2003) 0.96
Histories of depression, allopregnanolone responses to stress, and premenstrual symptoms in women. Biol Psychol (2005) 0.96
Selective serotonin reuptake inhibitors for premenstrual syndrome. Cochrane Database Syst Rev (2002) 0.95
Patch-clamp analysis of direct steroidal modulation of glutamate receptor-channels. J Neuroendocrinol (1994) 0.95
Progesterone withdrawal increases the alpha4 subunit of the GABA(A) receptor in male rats in association with anxiety and altered pharmacology - a comparison with female rats. Neuropharmacology (2002) 0.94
Profiling neurosteroids in cerebrospinal fluids and plasma by gas chromatography/electron capture negative chemical ionization mass spectrometry. Anal Biochem (2000) 0.94
Estrogen increases the density of 5-hydroxytryptamine(2A) receptors in cerebral cortex and nucleus accumbens in the female rat. J Steroid Biochem Mol Biol (1995) 0.93
Changes in GABAA receptor gamma 2 subunit gene expression induced by long-term administration of oral contraceptives in rats. Neuropharmacology (2002) 0.93
Oral contraceptives and mood in women with and without premenstrual dysphoria: a theoretical model. Arch Womens Ment Health (2005) 0.92
Reduced benzodiazepine sensitivity in patients with premenstrual syndrome: a pilot study. Psychoneuroendocrinology (1997) 0.91
Oral contraceptives in premenstrual syndrome: a randomized comparison of triphasic and monophasic preparations. Contraception (1992) 0.91
Locally applied estrogens potentiate glutamate-evoked excitation of cerebellar Purkinje cells. Brain Res (1988) 0.88
Citalopram increases pregnanolone sensitivity in patients with premenstrual syndrome: an open trial. Psychoneuroendocrinology (1998) 0.87
The effects of estrogen, progesterone, and ionized calcium on seizures during the menstrual cycle of epileptic women. Epilepsia (1987) 0.87
The interaction of neuroactive steroids and GABA in the development of neuropsychiatric disorders in women. Pharmacol Biochem Behav (2006) 0.87
Polyamine analogue regulation of NMDA MK-801 binding: a structure-activity study. J Med Chem (1996) 0.86
Drospirenone/ethinylestradiol 3mg/20microg (24/4 day regimen): a review of its use in contraception, premenstrual dysphoric disorder and moderate acne vulgaris. Drugs (2007) 0.86
Epilepsy in women: the science of why it is special. Neurology (1999) 0.85
Altered sensitivity to alcohol in the late luteal phase among patients with premenstrual dysphoric disorder. Psychoneuroendocrinology (2004) 0.85
The use of an LHRH agonist, buserelin, in the long-term management of premenstrual syndromes. Clin Endocrinol (Oxf) (1987) 0.84
Provocation of panic with carbon dioxide inhalation in patients with premenstrual dysphoria. Psychiatry Res (1989) 0.84
The effect of a synthetic GnRH analogue on catamenial epilepsy: a study in ten patients. J Neurol (1992) 0.83
Increase of estrogen dose deteriorates mood during progestin phase in sequential hormonal therapy. J Clin Endocrinol Metab (2003) 0.83
Adrenal response to adrenocorticotropic hormone stimulation in patients with premenstrual syndrome. Gynecol Endocrinol (2004) 0.83
Luteal phase treatment of premenstrual dysphoric disorder improves symptoms that continue into the postmenstrual phase. J Affect Disord (2005) 0.83
Effects of acute estradiol on 5-hydroxytryptamine and dopamine receptor subtype mRNA expression in female rat brain. Mol Cell Neurosci (1993) 0.83
Termination of pseudopregnancy in the rat produces an anxiogenic-like response that is associated with an increase in benzodiazepine receptor binding density and a decrease in GABA-stimulated chloride influx in the hippocampus. Brain Res Bull (2005) 0.82
Steroid requirements for regulation of the alpha4 subunit of the GABA(A) receptor in an in vitro model. Neurosci Lett (2006) 0.82
Psychological effect of the oral contraceptive formulation containing 3 mg of drospirenone plus 30 microg of ethinyl estradiol. Fertil Steril (2004) 0.82
Spontaneous anovulation causing disappearance of cyclical symptoms in women with the premenstrual syndrome. Acta Endocrinol (Copenh) (1991) 0.81
Induced anovulation as treatment of premenstrual tension syndrome. A double-blind cross-over study with GnRH-agonist versus placebo. Acta Obstet Gynecol Scand (1988) 0.81
Postpartum depression in women with epilepsy versus women without epilepsy. Epilepsy Behav (2006) 0.81
Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression. Arch Gen Psychiatry (2004) 3.64
Slow transcranial magnetic stimulation, long-term depotentiation, and brain hyperexcitability disorders. Am J Psychiatry (2002) 2.03
Increase in prefrontal cortex serotonin 2A receptors following estrogen treatment in postmenopausal women. Am J Psychiatry (2003) 1.77
Rating scales, scales of measurement, issues of reliability: resolving some critical issues for clinicians and researchers. J Nerv Ment Dis (2006) 1.56
Onset and exacerbation of obsessive-compulsive disorder in pregnancy and the postpartum period. J Clin Psychiatry (2010) 1.47
A meta-analysis of treatments for perinatal depression. Clin Psychol Rev (2011) 1.43
Adjunctive oral ziprasidone in patients with acute mania treated with lithium or divalproex, part 2: influence of protocol-specific eligibility criteria on signal detection. J Clin Psychiatry (2012) 1.42
PSTPIP is a substrate of PTP-PEST and serves as a scaffold guiding PTP-PEST toward a specific dephosphorylation of WASP. J Biol Chem (2001) 1.37
Effect of estrogen-serotonin interactions on mood and cognition. Behav Cogn Neurosci Rev (2005) 1.34
Reduced graft function (with or without dialysis) vs immediate graft function--a comparison of long-term renal allograft survival. Nephrol Dial Transplant (2006) 1.19
Relapse of major depression in women who continue or discontinue antidepressant medication during pregnancy. Am J Psychiatry (2013) 1.16
Language lateralization in epilepsy patients: fMRI validated with the Wada procedure. Epilepsia (2009) 1.14
Neurometabolism in human epilepsy. Epilepsia (2008) 1.12
Estrogen and the prefrontal cortex: towards a new understanding of estrogen's effects on executive functions in the menopause transition. Hum Brain Mapp (2012) 1.12
Utilization and barriers to mental health services among depressed medical interns: a prospective multisite study. J Grad Med Educ (2010) 1.10
Cortical gamma-aminobutyric acid levels and the recovery from ethanol dependence: preliminary evidence of modification by cigarette smoking. Biol Psychiatry (2005) 1.10
Towards a consensus on diagnostic criteria, measurement and trial design of the premenstrual disorders: the ISPMD Montreal consensus. Arch Womens Ment Health (2011) 1.09
123I-5-IA-85380 SPECT imaging of nicotinic acetylcholine receptor availability in nonsmokers: effects of sex and menstrual phase. J Nucl Med (2007) 1.08
An open trial of morning light therapy for treatment of antepartum depression. Am J Psychiatry (2002) 1.06
Rapid HIV testing in large urban jails. Am J Public Health (2012) 1.05
Effects of estrogen variation on neural correlates of emotional response inhibition. Neuroimage (2006) 1.04
The impact of gabapentin administration on brain GABA and glutamate concentrations: a 7T ¹H-MRS study. Neuropsychopharmacology (2012) 1.03
Preclinical evaluation of carcinoembryonic cell adhesion molecule (CEACAM) 6 as potential therapy target for pancreatic adenocarcinoma. J Pathol (2009) 1.02
Seizure clustering during epilepsy monitoring. Epilepsia (2002) 1.02
Elevated risk of adverse obstetric outcomes in pregnant women with depression. Arch Womens Ment Health (2013) 0.99
The corollary discharge in humans is related to synchronous neural oscillations. J Cogn Neurosci (2010) 0.98
Prenatal programming of mental illness: current understanding of relationship and mechanisms. Curr Psychiatry Rep (2015) 0.96
Increased peripheral blood expression of electron transport chain genes in bipolar depression. Bipolar Disord (2010) 0.94
A mixed methods evaluation of the effect of the protect and respect intervention on the condom use and disclosure practices of women living with HIV/AIDS. AIDS Behav (2009) 0.93
A survey of patient acceptability of repetitive transcranial magnetic stimulation (TMS) during pregnancy. J Affect Disord (2010) 0.92
Review of microdialysis in brain tumors, from concept to application: first annual Carolyn Frye-Halloran symposium. Neuro Oncol (2004) 0.92
Long-term outcome of vagus nerve stimulation for refractory partial epilepsy. Epilepsy Behav (2003) 0.90
Platelet serotonin in newborns and infants: ontogeny, heritability, and effect of in utero exposure to selective serotonin reuptake inhibitors. Pediatr Res (2004) 0.89
ISPMD consensus on the management of premenstrual disorders. Arch Womens Ment Health (2013) 0.89
Neonatal outcomes with the use of lamotrigine for bipolar disorder in pregnancy and breastfeeding: a case series and review of the literature. Psychopharmacol Bull (2009) 0.88
A comparison of long-term graft survival rates between the first and second donor kidney transplanted--the effect of a longer cold ischaemic time for the second kidney. Am J Transplant (2005) 0.88
The interaction of neuroactive steroids and GABA in the development of neuropsychiatric disorders in women. Pharmacol Biochem Behav (2006) 0.87
Estradiol and tryptophan depletion interact to modulate cognition in menopausal women. Neuropsychopharmacology (2006) 0.86
Preventing postpartum depression: a meta-analytic review. Clin Psychol Rev (2013) 0.84
The Protect and Respect program: a sexual risk reduction intervention for women living with HIV/AIDS. AIDS Behav (2007) 0.84
Antepartum depression: treatment with computer-assisted cognitive-behavioral therapy. Am J Psychiatry (2013) 0.82
Myeloproliferative disorders and the hyperviscosity syndrome. Emerg Med Clin North Am (2009) 0.81
7T MR spectroscopic imaging in the localization of surgical epilepsy. Epilepsia (2013) 0.81
The relationship between bipolar disorder, seasonality, and premenstrual symptoms. Curr Psychiatry Rep (2011) 0.80
Pharmacotherapy of postpartum depression: an update. Expert Opin Pharmacother (2014) 0.80
Myeloproliferative disorders and the hyperviscosity syndrome. Hematol Oncol Clin North Am (2010) 0.79
Female puberty: clinical implications for the use of prolactin-modulating psychotropics. Child Adolesc Psychiatr Clin N Am (2006) 0.79
Selective serotonin reuptake inhibitors and endothelial function in women. J Womens Health (Larchmt) (2014) 0.79
Computer-assisted cognitive behavioral therapy for pregnant women with major depressive disorder. J Womens Health (Larchmt) (2014) 0.79
Management of postpartum depression. J Midwifery Womens Health (2013) 0.79
Cerebrospinal fluid interleukin-6 in obsessive-compulsive disorder and trichotillomania. Psychiatry Res (2002) 0.78
Switching from quetiapine to ziprasidone: a sixteen-week, open-label, multicenter study evaluating the effectiveness and safety of ziprasidone in outpatient subjects with schizophrenia or schizoaffective disorder. J Psychiatr Pract (2011) 0.78
Guidelines for the management of depression during pregnancy. Curr Psychiatry Rep (2010) 0.77
Depressed neuroplasticity in major depressive disorder? Biol Psychiatry (2007) 0.77
Premenstrual dysphoric disorder and the brain. Am J Psychiatry (2013) 0.77
Emotional fronto-cingulate cortex activation and brain derived neurotrophic factor polymorphism in premenstrual dysphoric disorder. Hum Brain Mapp (2014) 0.77
Predictors of anxiety symptoms in the gynecological outpatient setting: The Thai experience. Int J Psychiatry Clin Pract (2009) 0.77
A randomized, placebo-controlled, double-blind trial of sertraline for postpartum depression. Psychopharmacology (Berl) (2013) 0.77
Effect of cytomegalovirus prophylaxis with acyclovir on renal transplant survival. Ren Fail (2008) 0.76
A sequencing-based survey of functional APAF1 alleles in a large sample of individuals with affective illness and population controls. Am J Med Genet B Neuropsychiatr Genet (2010) 0.75
The relationship between maternal attitudes and symptoms of depression and anxiety among pregnant and postpartum first-time mothers. Arch Womens Ment Health (2014) 0.75
Effects of sex and gender on adaptation to space: behavioral health. J Womens Health (Larchmt) (2014) 0.75
Advances in the translational neuroscience of neurosteroids. Psychopharmacology (Berl) (2006) 0.75
Defensive projection, superimposed on simplistic object relations, erodes patient-provider relationships in high-risk pregnancy: an empirical investigation. J Am Psychoanal Assoc (2010) 0.75
Adjunctive oral ziprasidone in patients with acute mania treated with lithium or divalproex, part 1: results of a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry (2012) 0.75
A new model for quantifying the extent of interaction between soluble polyphenylene-vinylenes and single-walled carbon nanotubes in solvent dispersions. J Phys Chem B (2010) 0.75
Central nervous system effects of prenatal selective serotonin reuptake inhibitors: sensing the signal through the noise. Psychopharmacology (Berl) (2013) 0.75
The impact of donor spontaneous intracranial haemorrhage vs. other donors on long-term renal graft and patient survival. Clin Transplant (2006) 0.75